IT vs QNCX · P/E 16, rev $3.19B vs $79.3M cap
Gartner Inc (IT) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Latest reported IT revenue for 2026-06-30 was $3.19B. Net income was $497.8M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
QNCX does not have a complete income-statement cache yet.
IT currently screens at market cap $11.03B and trailing P/E 16.3. QNCX currently screens at market cap $79.3M.
Not investment advice. Open the IT and QNCX stock pages for the full models.
Not investment advice.